Drug intolerance: age-related aspects

Abstract

BACKGROUND: Drug hypersensitivity is an adverse reaction caused by immune or non-immune mechanisms to the intake of adequate doses of drugs. To avoid a dangerous situation, correctly collected pharmacological history, taking into account all the characteristics of the patient (gender, age, concomitant pathology), and knowledge of the mechanism of action of drugs can help a practicing physician who does not currently have a reliable method for diagnosing drug hypersensitivity.
 AIM: Identification of age-specific drug intolerance.
 MATERIALS AND METHODS: The study was conducted from 2017 to 2020 and included 200 outpatient medical history forms of individuals diagnosed with an unspecified pathological reaction to a drug or medication. All drug reactions were based on patients own statements and were allocated as dichotomous variables. The results were analyzed by nonparametric statistics (Pearsons chi-square).
 RESULTS: Three groups of patients were identified: 1844 years (n=49), 4560 years (n=60), 61 (n=91). The odds of incomprehensible reactions were 2.2 times higher in patients in group 3 than in patients in the other groups. Group 3 patients were 12 times more likely to have an itchy reaction to medications than patients in the other groups. Group 1 patients were 3 times more likely to have urticaria than patients in groups 2 and 3. The odds of drug intolerance to angiotensin-converting enzyme (ACE) inhibitors were 2.6 times higher in patients in group 3 than in patients in the other groups. When comparing clinical manifestations of drug intolerance to penicillin and cephalosporin antibiotics, no significant differences were found in all patients. The presence of allergies and somatic pathology of 3 systems did not significantly affect the possibility of reactions of varying severity to 3 drugs in these groups.
 CONCLUSIONS: Patients age has no effect on the possibility of reactions to certain groups of drugs. The exception was ACE inhibitors, which is most likely due to the higher frequency of prescribing antihypertensive therapy in patients in this age group. The aggravation of clinical manifestations and the occurrence of polypharmacy are not associated with age and comorbid background. Age and non-life-threatening clinical manifestations of drug intolerance were correlated, which indicates the absence of the reliable effect of age on the possibility of anaphylactic shock or angioedema.